• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ABT

ABT

Abbott Laboratories

NYSEHealthcareMedical - DevicesUS

USD87.02

+0.05 (+0.06%)

Rating:B+

Company Profile

CEO

Robert Ford

IPO Date

1980-03-17

Sector

Healthcare

Industry

Medical - Devices

Exchange

NYSE

Country

US

Market Metrics

Open

$87.19

Prev. Close

$86.97

Day Low

$86.72

Day High

$88.11

52W Low

$81.97

52W High

$139.06

Market Cap

$151.57B

Volume

10.38M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

38.2%

Avg Negative

25.1%

Avg Neutral

36.7%

News Feed

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

zacks.com·5/28/2026·↓ negative

Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know

zacks.com·5/27/2026·↑ positive

How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026

zacks.com·5/27/2026·↓ negative

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

prnewswire.com·5/27/2026·↑ positive

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

prnewswire.com·5/27/2026·↑ positive

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026

prnewswire.com·5/26/2026·↑ positive

Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum

zacks.com·5/20/2026·↑ positive

The Dip That Keeps On Dipping: 2 Strong Buy Stocks Near 52-Week Lows With 50%+ Upside Potential

seekingalpha.com·5/19/2026·↑ positive

How Abbott's Volume-Driven Nutrition Strategy Is Shaping Up

zacks.com·5/15/2026·↓ negative

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

zacks.com·5/12/2026·↓ negative